These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 27327217

  • 1. Mirtazapine in comorbid major depression and an alcohol use disorder: A double-blind placebo-controlled pilot trial.
    Cornelius JR, Chung T, Douaihy AB, Kirisci L, Glance J, Kmiec J, FitzGerald D, Wesesky MA, Salloum I.
    Psychiatry Res; 2016 Aug 30; 242():326-330. PubMed ID: 27327217
    [Abstract] [Full Text] [Related]

  • 2. The effects of mirtazapine versus placebo on alcohol consumption in male high consumers of alcohol: a randomized, controlled trial.
    de Bejczy A, Söderpalm B.
    J Clin Psychopharmacol; 2015 Feb 30; 35(1):43-50. PubMed ID: 25517204
    [Abstract] [Full Text] [Related]

  • 3. Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder.
    Cornelius JR, Bukstein OG, Wood DS, Kirisci L, Douaihy A, Clark DB.
    Addict Behav; 2009 Oct 30; 34(10):905-9. PubMed ID: 19321268
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
    Carpenter LL, Yasmin S, Price LH.
    Biol Psychiatry; 2002 Jan 15; 51(2):183-8. PubMed ID: 11822997
    [Abstract] [Full Text] [Related]

  • 5. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.
    Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A.
    Health Technol Assess; 2013 Feb 15; 17(7):1-166. PubMed ID: 23438937
    [Abstract] [Full Text] [Related]

  • 6. Early Improvements in Individual Symptoms to Predict Later Remission in Major Depressive Disorder Treated With Mirtazapine.
    Funaki K, Nakajima S, Suzuki T, Mimura M, Uchida H.
    J Clin Pharmacol; 2016 Sep 15; 56(9):1111-9. PubMed ID: 26813241
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients.
    Thase ME, Nierenberg AA, Keller MB, Panagides J, Relapse Prevention Study Group.
    J Clin Psychiatry; 2001 Oct 15; 62(10):782-8. PubMed ID: 11816867
    [Abstract] [Full Text] [Related]

  • 8. An open-label pilot study of quetiapine plus mirtazapine for heavy drinkers with alcohol use disorder.
    Brunette MF, Akerman SC, Dawson R, O'Keefe CD, Green AI.
    Alcohol; 2016 Jun 15; 53():45-50. PubMed ID: 27256763
    [Abstract] [Full Text] [Related]

  • 9. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.
    Szegedi A, Jansen WT, van Willigenburg AP, van der Meulen E, Stassen HH, Thase ME.
    J Clin Psychiatry; 2009 Mar 15; 70(3):344-53. PubMed ID: 19254516
    [Abstract] [Full Text] [Related]

  • 10. Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: a four-week, randomized, double-blinded, placebo-controlled study.
    Ng CG, Boks MP, Roes KC, Zainal NZ, Sulaiman AH, Tan SB, de Wit NJ.
    Eur Neuropsychopharmacol; 2014 Apr 15; 24(4):491-8. PubMed ID: 24503279
    [Abstract] [Full Text] [Related]

  • 11. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
    Winokur A, DeMartinis NA, McNally DP, Gary EM, Cormier JL, Gary KA.
    J Clin Psychiatry; 2003 Oct 15; 64(10):1224-9. PubMed ID: 14658972
    [Abstract] [Full Text] [Related]

  • 12. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N, Tedeschini E, Bentley KH, Evins AE, Papakostas GI.
    J Clin Psychiatry; 2011 Aug 15; 72(8):1144-51. PubMed ID: 21536001
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
    Kim JE, Yoon SJ, Kim J, Jung JY, Jeong HS, Cho HB, Shin E, Lyoo IK, Kim TS.
    Int J Clin Pract; 2011 Mar 15; 65(3):323-9. PubMed ID: 21314870
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of risperidone augmentation to antidepressants in the management of suicidality in major depressive disorder: a randomized, double-blind, placebo-controlled pilot study.
    Reeves H, Batra S, May RS, Zhang R, Dahl DC, Li X.
    J Clin Psychiatry; 2008 Aug 15; 69(8):1228-1236. PubMed ID: 18681749
    [Abstract] [Full Text] [Related]

  • 15. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, Tulner DM, Schins A, Crijns HJ, Kuijpers PM, Vossen H, Lousberg R, Ormel J, MIND-IT investigators.
    Psychosom Med; 2007 Aug 15; 69(7):606-13. PubMed ID: 17846258
    [Abstract] [Full Text] [Related]

  • 16. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
    Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN.
    J Clin Psychiatry; 2005 Apr 15; 66(4):515-20. PubMed ID: 15816795
    [Abstract] [Full Text] [Related]

  • 17. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA, OPERATION Study Team.
    J Clin Psychopharmacol; 2010 Aug 15; 30(4):357-64. PubMed ID: 20571433
    [Abstract] [Full Text] [Related]

  • 18. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P, Ward HE, Tremblay P, Laberge L, Hébert C, Bergeron R.
    Am J Psychiatry; 2010 Mar 15; 167(3):281-8. PubMed ID: 20008946
    [Abstract] [Full Text] [Related]

  • 19. Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase.
    Terevnikov V, Stenberg JH, Tiihonen J, Joffe M, Burkin M, Tchoukhine E, Joffe G.
    Hum Psychopharmacol; 2011 Apr 15; 26(3):188-93. PubMed ID: 21469215
    [Abstract] [Full Text] [Related]

  • 20. Mirtazapine in Comorbid Major Depression and Alcohol Dependence: An Open-Label Trial.
    Cornelius JR, Douaihy AB, Clark DB, Chung T, Wood DS, Daley D.
    J Dual Diagn; 2012 Sep 01; 8(3):200-204. PubMed ID: 23230395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.